about
Principles in Management of Soft Tissue SarcomaComplete pathologic response to neoadjuvant radiotherapy is predictive of oncological outcome in patients with soft tissue sarcoma.Radiographic and histologic response to neoadjuvant radiotherapy in patients with soft tissue sarcomaCombining targeted agents with modern radiotherapy in soft tissue sarcomas.Primitive sarcoma of the breast: new insight on the proper surgical management.Oncological outcome and prognostic factors in the therapy of soft tissue sarcoma of the extremities.Multiple spinal metastases from a well-differentiated liposarcoma of the iliac wing: a case report.Current concepts and future perspectives in retroperitoneal soft-tissue sarcoma management.Liposarcoma: molecular genetics and therapeutics.Treatment of adult soft tissue sarcoma: old concepts, new insights, and potential for drug discovery.Management of recurrent retroperitoneal sarcoma.Outcomes in the management of adult soft tissue sarcomas.Follow-up of the soft tissue sarcoma patient.Management of Recurrent Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach from the Trans-Atlantic RPS Working Group.Semi-automated volumetric quantification of tumor necrosis in soft tissue sarcoma using contrast-enhanced MRI.Prognostic factors for reoperation of recurrent retroperitoneal sarcoma: The role of clinicopathological factors other than histologic grade.Contiguous organ resection is safe in patients with retroperitoneal sarcoma: An ACS-NSQIP analysis.[Isolated limb perfusion for liposarcoma : Histopathological response and subgroup analysis after TNF melphalan-based ILP].
P2860
Q26795619-FB739CE0-FF6F-4620-9A07-35A7117F86FDQ34129461-E1D03743-3781-4648-BDC6-F604B3D2E8B9Q34138698-10DC1C22-5A6B-45AE-A485-F4286B17057FQ34396047-3688A586-0841-4F88-A970-CA41CD0DEA3CQ35899940-ED519D59-7C8C-496B-8C7F-6C4039F41931Q36765829-78788AB5-DF15-4AD1-95EC-6FAD622DDF77Q37456128-4315976B-EC54-4BB8-BAD2-C20C6DCDD9DEQ37577928-F8AB34BA-A733-4154-B0B9-3D1D64F9000CQ37831160-1EDE87DD-E008-408B-8468-FA8D53C2447FQ38000323-5321EAFA-448F-4F39-92C1-4F5FF77042DBQ38155133-B13B6D55-5C7D-4596-880E-4461FF20FF4BQ38223237-FD9540C2-B1BF-4C8F-8E1A-16E281EE4DFAQ38260837-53850D1F-33E5-4F98-863D-8464A8EA66B2Q41403507-31B10558-0BFE-44C6-8872-875518C39C52Q41810446-8382A484-E55B-46FB-BF1D-62F03C5EC6ACQ44875403-68E3C323-E8AB-4138-87D7-BDF9EA47C05BQ46030290-046D4B60-C75B-405B-BCAD-63890CAB08D3Q53675851-724DC4FB-2BED-4F3F-BAB3-806AD5524300
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Why do patients with low-grade soft tissue sarcoma die?
@en
Why do patients with low-grade soft tissue sarcoma die?
@nl
type
label
Why do patients with low-grade soft tissue sarcoma die?
@en
Why do patients with low-grade soft tissue sarcoma die?
@nl
prefLabel
Why do patients with low-grade soft tissue sarcoma die?
@en
Why do patients with low-grade soft tissue sarcoma die?
@nl
P2860
P50
P1476
Why do patients with low-grade soft tissue sarcoma die?
@en
P2093
Cristina R Ferrone
Li-Xuan Qin
P2860
P2888
P304
P356
10.1245/S10434-008-0163-0
P577
2008-10-01T00:00:00Z
P5875
P6179
1014256357